tiprankstipranks
Trending News
More News >

NetraMark Appoints Industry Veteran as Chief Strategist

Story Highlights
NetraMark Appoints Industry Veteran as Chief Strategist

NetraMark Holdings (TSE:AIAI) has released an update.

Confident Investing Starts Here:

NetraMark Holdings has appointed Angelico Carta, co-founder of Worldwide Clinical Trials, as its Chief Strategy Officer to drive the company’s long-term strategy and growth. With over 35 years of experience in clinical development, Carta will leverage his vast expertise to enhance NetraMark’s AI-driven solutions in clinical trials and precision medicine. This strategic move aims to strengthen NetraMark’s leadership in the pharmaceutical industry and improve patient outcomes globally.

For further insights into TSE:AIAI stock, check out TipRanks’ Stock Analysis page.

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.

Report an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App